Gamma-delta T cells in glioblastoma immunotherapy

Gamma-delta T cells in glioblastoma immunotherapy

Conventional immunotherapy in the treatment of glioblastoma (GBM) has essentially produced no significant advantage over the use of chemotherapeutic drugs. A strongly immunosuppressive tumor microenvironment and lack of antigen-presenting major histocompatibility expression on tumor cells have made...

Full description

Bibliographic Details
Main Author: Sadhak Sengupta
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Glioma
Subjects:
Cancers
glioblastoma
immunotherapy
T cells
tumors
Vγ9 Vδ2 T cells
γδ T cells
Online Access:http://www.jglioma.com/article.asp?issn=2589-6113;year=2019;volume=2;issue=1;spage=30;epage=36;aulast=Sengupta

Internet

http://www.jglioma.com/article.asp?issn=2589-6113;year=2019;volume=2;issue=1;spage=30;epage=36;aulast=Sengupta

Similar Items